Related Experiment Video

Updated: Jul 30, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 18, 2011

Targeting the DNA repair defect of BRCA tumours

Nicholas Turner1, Andrew Tutt, Alan Ashworth

  • 1The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, Fulham Road, London SW3 6JB, UK.

Current Opinion in Pharmacology
|June 16, 2005
PubMed

Insights

Individuals with BRCA1 or BRCA2 mutations have a higher risk of breast and ovarian cancers. Targeting DNA repair deficiencies in these BRCA-deficient tumors with specific drugs offers a potential treatment strategy.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Germline mutations in BRCA1 or BRCA2 significantly increase predisposition to breast and ovarian cancers.
  • Tumors in these individuals often exhibit loss of the wild-type BRCA1 or BRCA2 allele, leading to functional deficiency.
  • BRCA1 and BRCA2 proteins are crucial for repairing DNA double-strand breaks via homologous recombination.

Purpose of the Study:

  • To explore the therapeutic potential of exploiting BRCA1/BRCA2 deficiency in cancer treatment.
  • To investigate strategies for targeting BRCA-deficient tumors.

Main Methods:

  • This study focuses on the functional role of BRCA1 and BRCA2 in DNA repair.
  • It proposes a therapeutic approach based on creating DNA damage in cancer cells.

Main Results:

  • BRCA-deficient cancers are characterized by impaired homologous recombination repair.
  • This impairment presents a vulnerability that can be targeted therapeutically.

Conclusions:

  • Targeting DNA damage pathways in BRCA-deficient cancers is a promising therapeutic avenue.
  • Exploiting the functional deficit of BRCA1 or BRCA2 in tumors could lead to effective cancer treatments.

More Related Videos

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

Related Concept Videos

Base Excision Repair01:54

Base Excision Repair

One of the common DNA damages is the chemical alteration of single bases by alkylation, oxidation, or deamination. The altered bases cause mispairing and strand breakage during replication. This type of damage causes minimal change to the DNA double helix structure and can be repaired by the base excision repair (BER) pathways. BER corrects damaged DNA sequences by removing the damaged base and restoring the original base sequence using the complementary strand as a template.
The first step of...
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...